Recurrent Urinary Tract Infections (rUTI)

Symptoms, Causes, and Prevention

Symptomatic, recurrent lower urinary tract infections (rUTI) in women are a common condition for which best practice guidelines related to treatment and prevention have not been well established. rUTI affects women of all ages and is defined as 2 or more symptomatic episodes in 6 months or 3 episodes in 1 year. Between 20% to 30% of women who have one UTI will have a rUTI, and approximately 25% of these women will have more recurrent episodes.

Symptoms of rUTI may typically include burning with urination, foul-smelling urine, urinary urgency, and frequency. Treatment strategies should focus on relieving symptoms while at the same time preventing the overuse of antibiotics, which can cause increased side effects as well as the development of antibiotic resistance.

Who Is At Risk of rUTI?

For premenopausal women, sexual activity can be associated with rUTI.
Birth control products such as nonoxynol-9 spermicide can be a risk factor as well.
Lack of estrogen in postmenopausal women can lead to vaginal atrophy, acidic PH changes, and overgrowth of bacteria, leading to UTI

What Type of Work-Up Is Needed to Treat rUTI?

A urine culture before antibiotic treatment is important to document infection and help determine the optimal antibiotic treatment. More complex cases may require renal imaging or cystoscopy.

How is rUTI Best Treated?

Short-course treatment of 3-5 days is recommended. Preferred first-line antibiotics are Nitrofurantoin, Trimethoprim-Sulfamethoxazole, and Fosfomycin. Fluoroquinolones such as Cipro are discouraged.

rUTI Prevention Strategies:

Some prevention strategies include lifestyle and behavioral modifications:

Controlling blood glucose in diabetics is important
Sexually active women should avoid spermicide gel use. It is unclear whether voiding after intercourse is useful
Avoid unnecessary or prolonged antibiotic use (more than 5 days)
Maintain adequate hydration

Therapeutic Interventions

Antibiotic Treatments

Antibiotic prophylaxis may sometimes be indicated and can be administered in several ways.
- The use of a single low-dose antibiotic immediately after intercourse can be very effective in preventing.
- Once-daily low-dose antibiotics for 6-12 months may be required at times and are effective.
- A patient self-starting a 3-day course of antibiotics can be a convenient way to treat intermittent. It is best to obtain a urine culture before starting treatment.

Nonantibiotic Therapy

While commonly used to prevent rUTI, little data support the use of Cranberry products or D-mannose. The value of oral and vaginal probiotics is questionable.

Vaginal estrogen therapy reduces vaginal PH, reduces bacterial colonization, restores lactobacillus, and reduces rUTI in postmenopausal women. There is no documentation of increased breast cancer risk or rise in serum Estrogen levels. Oral estrogens do not reduce the risk of UTI.

Methenamine Hippurate

This is a bacteriostatic agent that increases urinary formaldehyde levels. It does not promote antibiotic resistance. There is some evidence that using methenamine as prophylaxis may help prevent rUTI and reduce the need for prophylactic antibiotics.

Vaccines

OM-89 (Uro-Vaxom) is an oral vaccine only available in Europe. It appears to be safe and eﬀective in reducing rUTI. Hopefully, this will be available in the U.S. soon

rUTIs are frustrating for women and can significantly impact the quality of life and daily activities. Identifying underlying risk factors is important. There are potentially preventive measures worth discussing with your doctor.

If you have any more questions about the treatment and prevention of rUTIs in women, schedule an appointment with a Georgia Urology expert today.